Monedas fiat
Criptomonedas
No hay resultados para ""
No pudimos encontrar nada que coincida con su búsqueda. Vuelva a intentarlo con un término diferente.
NewLimit - Series A
Panorama
Acerca de NewLimit - Series A
Inversor
Inversores | Tipear | Ubicación | Año de fundación | #Empresas de portafolio | Dirección de correo electrónico | Sociales |
---|---|---|---|---|---|---|
Fund | United States of America | -- | 1 | -- | ||
Fund | United States of America | 1972 | 15 | [email protected] | ||
Fund | United States of America | 2005 | 36 | [email protected] | ||
Angel Investor | -- | -- | 2 | -- | ||
Angel Investor | United States of America | -- | 7 | -- |
Fundadores & Equipo
Brian Armstrong
Greg Johnson
Jacob Kimmel
Perfil de la empresa / Presentación del proyecto
NewLimit was founded to cure aging. They are working toward this goal by uncovering sets of transcription factors that can epigenetically reprogram cells. Although its products are designed to treat aging itself, NewLimit also believe these products could treat or prevent many diseases associated with aging, including fibrosis, infectious disease, and neurodegenerative disease.